|
1
|
Ververidis F, Trantas E, Douglas C,
Vollmer G, Kretzschmar G and Panopoulos N: Biotechnology of
flavonoids and other phenylpropanoid-derived natural products. Part
I: Chemical diversity, impacts on plant biology and human health.
Biotechnol J. 2:1214–1234. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zamora-Ros R, Touillaud M, Rothwell JA,
Romieu I and Scalbert A: Measuring exposure to the polyphenol
metabolome in observational epidemiologic studies: Current tools
and applications and their limits. Am J Clin Nutr. 100:11–26. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Prior RL and Wu X: Anthocyanins:
Structural characteristics that result in unique metabolic patterns
and biological activities. Free Radic Res. 40:1014–1028. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mazza G and Miniati E: Anthocyanins in
fruits, vegetables, and grains. CRC Press; Boca Raton: 1993
|
|
5
|
Favot L, Martin S, Keravis T,
Andriantsitohaina R and Lugnier C: Involvement of cyclin-dependent
pathway in the inhibitory effect of delphinidin on angiogenesis.
Cardiovasc Res. 59:479–487. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lamy S, Lafleur R, Bédard V, Moghrabi A,
Barrette S, Gingras D and Béliveau R: Anthocyanidins inhibit
migration of glioblastoma cells: Structure-activity relationship
and involvement of the plasminolytic system. J Cell Biochem.
100:100–111. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Noda Y, Kaneyuki T, Mori A and Packer L:
Antioxidant activities of pomegranate fruit extract and its
anthocyanidins: Delphinidin, cyanidin, and pelargonidin. J Agric
Food Chem. 50:166–171. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ozbay T and Nahta R: Delphinidin inhibits
HER2 and Erk1/2 signaling and suppresses growth of
HER2-overexpressing and triple negative breast cancer cell lines.
Breast cancer (Auckl). 5:143–154. 2011.PubMed/NCBI
|
|
9
|
Ko H, Jeong MH, Jeon H, Sung GJ, So Y, Kim
I, Son J, Lee SW, Yoon HG and Choi KC: Delphinidin sensitizes
prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5
and causing caspase-mediated HDAC3 cleavage. Oncotarget.
6:9970–9984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pal HC, Sharma S, Strickland LR, Agarwal
J, Athar M, Elmets CA and Afaq F: Delphinidin reduces cell
proliferation and induces apoptosis of non-small-cell lung cancer
cells by targeting EGFR/VEGFR2 signaling pathways. PLoS One.
8:e772702013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng R, Wang SY, Shi YH, Fan J and Yin XM:
Delphinidin induces necrosis in hepatocellular carcinoma cells in
the presence of 3-methyladenine, an autophagy inhibitor. J Agric
Food Chem. 58:3957–3964. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yun JM, Afaq F, Khan N and Mukhtar H:
Delphinidin, an anthocyanidin in pigmented fruits and vegetables,
induces apoptosis and cell cycle arrest in human colon cancer
HCT116 cells. Mol Carcinog. 48:260–270. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Filipiak K, Hidalgo M, Silvan JM, Fabre B,
Carbajo RJ, Pineda-Lucena A, Ramos A, de Pascual-Teresa B and de
Pascual-Teresa S: Dietary gallic acid and anthocyanin cytotoxicity
on human fibrosarcoma HT1080 cells. A study on the mode of action.
Food Funct. 5:381–389. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
de Hullu JA, van der Avoort IA, Oonk MH
and van der Zee AG: Management of vulvar cancers. Eur J Surg Oncol.
32:825–831. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kochli OR, Sevin BU, Averette HE and
Haller U: Overview of currently used chemosensitivity test systems
in gynecologic malignancies and breast cancer. Contrib Gynecol
Obstet. 19:12–23. 1994.PubMed/NCBI
|
|
16
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Raja FA, Chopra N and Ledermann JA:
Optimal first-line treatment in ovarian cancer. Ann Oncol. 23 Suppl
10:x118–x127. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Javadi S, Ganeshan DM, Qayyum A, Iyer RB
and Bhosale P: Ovarian cancer, the revised FIGO staging system and
the role of imaging. AJR Am J Roentgenol. 206:1351–1360. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Coleman RL, Monk BJ, Sood AK and Herzog
TJ: Latest research and treatment of advanced-stage epithelial
ovarian cancer. Nat Rev Clin Oncol. 10:211–224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tripathi V, Kumar R, Dinda AK, Kaur J and
Luthra K: CXCL12-CXCR7 signaling activates ERK and Akt pathways in
human choriocarcinoma cells. Cell Commun Adhes. 21:221–228. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hou DX, Fujii M, Terahara N and Yoshimoto
M: Molecular mechanisms behind the chemopreventive effects of
anthocyanidins. J Biomed Biotechnol. 2004:321–325. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hou DX, Yanagita T, Uto T, Masuzaki S and
Fujii M: Anthocyanidins inhibit cyclooxygenase-2 expression in
LPS-evoked macrophages: Structure-activity relationship and
molecular mechanisms involved. Biochemical pharmacology.
70:417–425. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lamy S, Blanchette M, Michaud-Levesque J,
Lafleur R, Durocher Y, Moghrabi A, Barrette S, Gingras D and
Béliveau R: Delphinidin, a dietary anthocyanidin, inhibits vascular
endothelial growth factor receptor-2 phosphorylation.
Carcinogenesis. 27:989–996. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Azevedo L, de Lima PL Alves, Gomes JC,
Stringheta PC, Ribeiro DA and Salvadori DMF: Differential response
related to genotoxicity between eggplant (Solanum melanogena) skin
aqueous extract and its main purified anthocyanin (delphinidin) in
vivo. Food Chem Toxicol. 45:852–858. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yeh CT and Yen GC: Induction of apoptosis
by the Anthocyanidins through regulation of Bcl-2 gene and
activation of c-Jun N-terminal kinase cascade in hepatoma cells. J
Agric Food Chem. 53:1740–1749. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Smolle E, Taucher V, Pichler M, Petru E,
Lax S and Haybaeck J: Targeting signaling pathways in epithelial
ovarian cancer. Int J Mol Sci. 14:9536–9555. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luo J, Manning BD and Cantley LC:
Targeting the PI3K-Akt pathway in human cancer: Rationale and
promise. Cancer Cell. 4:257–262. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Osaki M, Oshimura M and Ito H: PI3K-Akt
pathway: Its functions and alterations in human cancer. Apoptosis.
9:667–676. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ip CKM and Wong AST: Exploiting p70 S6
kinase as a target for ovarian cancer. Expert Opin Ther Tar.
16:619–630. 2012. View Article : Google Scholar
|
|
30
|
Meng Q, Xia C, Fang J, Rojanasakul Y and
Jiang BH: Role of PI3K and AKT specific isoforms in ovarian cancer
cell migration, invasion and proliferation through the p70S6K1
pathway. Cell Signal. 18:2262–2271. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pon YL, Zhou HY, Cheung AN, Ngan HY and
Wong AS: p70 S6 kinase promotes epithelial to mesenchymal
transition through snail induction in ovarian cancer cells. Cancer
Res. 68:6524–6532. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cheaib B, Auguste A and Leary A: The
PI3K/Akt/mTOR pathway in ovarian cancer: Therapeutic opportunities
and challenges. Chin J Cancer. 34:4–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Choi KC, Auersperg N and Leung PC:
Mitogen-activated protein kinases in normal and (pre)neoplastic
ovarian surface epithelium. Reprod Biol Endocrinol. 1:712003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Roberts PJ and Der CJ: Targeting the
Raf-MEK-ERK mitogen-activated protein kinase cascade for the
treatment of cancer. Oncogene. 26:3291–3310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nicosia SV, Bai W, Cheng JQ, Coppola D and
Kruk PA: Oncogenic pathways implicated in ovarian epithelial
cancer. Hematol Oncol Clin North Am. 17:927–943. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bin Hafeez B, Asim M, Siddiqui IA, Adhami
VM, Murtaza I and Mukhtar H: Delphinidin, a dietary anthocyanidin
in pigmented fruits and vegetables: A new weapon to blunt prostate
cancer growth. Cell Cycle. 7:3320–3326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fan W, Sun L, Zhou JQ, Zhang C, Qin S,
Tang Y, Liu Y, Lin SS and Yuan ST: Marsdenia tenacissima extract
induces G0/G1 cell cycle arrest in human esophageal carcinoma cells
by inhibiting mitogen-activated protein kinase (MAPK) signaling
pathway. Chin J Nat Med. 13:428–437. 2015.PubMed/NCBI
|
|
38
|
Li A, Wang J, Wu M, Zhang X and Zhang H:
The inhibition of activated hepatic stellate cells proliferation by
arctigenin through G0/G1 phase cell cycle arrest: Persistent
p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling
pathway. Eur J Pharmacol. 747:71–87. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lin CJ, Chen TL, Tseng YY, Wu GJ, Hsieh
MH, Lin YW and Chen RM: Honokiol induces autophagic cell death in
malignant glioma through reactive oxygen species-mediated
regulation of the p53/PI3K/Akt/mTOR signaling pathway. Toxicol Appl
Pharmacol. 304:59–69. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu E, Li J, Shi S, Wang X, Liang T, Wu B
and Li Q: Sustained ERK activation-mediated proliferation
inhibition of farrerol on human gastric carcinoma cell line by
G0/G1-phase cell-cycle arrest. Eur J Cancer Prev. 25:490–499. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Oh I, Cho H and Lee Y, Cheon M, Park D and
Lee Y: Blockage of autophagy rescues the dual PI3K/mTOR inhibitor
BEZ235-induced growth inhibition of colorectal cancer cells. Dev
Reprod. 20:1–10. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jia L, Zhang S, Ye Y, Li X, Mercado-Uribe
I, Bast RC Jr and Liu J: Paclitaxel inhibits ovarian tumor growth
by inducing epithelial cancer cells to benign fibroblast-like
cells. Cancer Lett. 326:176–182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lamendola DE, Duan Z, Yusuf RZ and Seiden
MV: Molecular description of evolving paclitaxel resistance in the
SKOV-3 human ovarian carcinoma cell line. Cancer Res. 63:2200–2205.
2003.PubMed/NCBI
|
